Aesthetic Medical International Holdings Group Ltd: Business Overview, Financials & Competitive Analysis

Aesthetic Medical International Holdings Group Ltd Overview

Aesthetic Medical International Holdings Group Ltd operates a multi-service aesthetic medical platform offering surgical treatments (eye surgery, rhinoplasty, breast augmentation, liposuction), non-surgical minimally invasive and energy-based treatments (laser, ultrasound, radiofrequency), and complementary healthcare services (dermatology, dentistry, hair loss treatment). The company operates treatment centers across major Chinese cities with focus on the Guangdong-Hong Kong-Macau Greater Bay area and Yangtze River Delta, leveraging over 20 years of clinical experience.

Strategic Profile

The company derives a majority of its revenue from non-surgical aesthetic medical services. The company transitioned to OTCQX Best Market trading in July 2024, signaling improved disclosure and governance standards for a China-based aesthetic medical services provider targeting Chinese consumers.

Competitive Landscape

China's aesthetic medicine market is fragmented with competitors including Hangzhou Meitu Technology (operator of Meitu online platform), Mediwound (non-surgical platforms), and numerous regional medical spas. Aesthetic Medical International competes on clinic network scale and breadth of services across surgical and non-surgical modalities. The sector faces regulatory headwinds including restrictions on medical advertising and pricing controls in China.

Industry Context

Aesthetic Medical International Holdings Group Ltd operates in Healthcare Services.

Key facts

Founded: 1997 · Headquarters: Shenzhen, China · Revenue: $755.67M (2024) · Market cap: $7.17M (as of April 2025)